START Trial demonstrates importance of early treatment – Who Will Pay?
Position paper On May 27th, 2015, the U.S. National Institute of Health released an article stating that the START Trial, short for Strategic Timing of Starting Antiretroviral Treatment, was stopped […]Read more
Test and treat from a human rights perspective
Since the late 2000s, biomedical approaches to HIV prevention and treatment have become increasingly central to global HIV and AIDS policy guidelines and initiatives. The reasons for this are complex. […]Read more
HIV and AIDS in the mandate of the Special Rapporteur on the Right to Health: genealogies, lessons learned, challenges that remain
On October 2014, a group of around 30 researchers, activists and human rights experts met in Delhi at the invitation of Anand Grover, the outgoing Special Rapporteur on the right […]Read more
Financing and the Post-2015 Agenda: Making the Case for HIV
The Post-2015 Scenario In September 2015, the UN General Assembly will be adapting a new set of development goals, with 2030 as its end-goal timeline. The proposed goals, currently referred […]Read more